ASPIRE-Hemophilia Apply

Eligibility

To be eligible for an ASPIRE Hemophilia Research Award, applicants must:
  • have a doctoral degree (MD, PhD, PharmD, or physiotherapy, social work, or advanced nursing degree), and
  • reside and practice in the United States.

Timeline

  • Applications must be received by Friday, March 31, 2017, 11:59 p.m. Eastern Daylight Time
  • Addenda, supplemental materials, changes, or updates will not be accepted after the deadline
  • Award decisions will be made and applicants will be notified by May 31, 2017
  • The final study report or an interim progress report (dependent on whether a one- or two-year Award is granted) will be expected on or before December 31, 2018

How to Apply

Applications should be submitted through Pfizer’s global investigator-initiated research website. Please click on the link below, select “Submit an IIR Request,” and follow the online instructions. If this is your first time visiting the portal, you must first “Create an Account.”

Please select 2017 ASPIRE Hemophilia Awards from the competitive program dropdown. The system will automatically populate the study title with correct program ID.

Completed application forms must be accompanied by the following documents:
  • Cover letter on institutional letterhead
  • Relevant articles from the applicant’s scientific publications (if applicable)
  • Description of preliminary work in proposed research topic
  • An abbreviated curriculum vitae (CV) (limited to 3 pages); NIH biosketch format will be accepted
  • Description of available research facilities
  • Listing of other research support with a description of overlap with ASPIRE application, if any, and, if applicable, a listing of proposed collaborators (including CVs)
  • Bibliography of relevant references
  • Itemized budget for proposed research

Click Here to Apply for a 2017 ASPIRE Hemophilia Research Award and Access the Pfizer Investigator-Initiated Research Site

Questions

Please see the Frequently Asked Questions (FAQ) page for help.

You may also e-mail questions to questions.aspireresearch-HEMOPHILIA@pfizer.com